Press coverage about Quorum Health Corporation (NYSE:QHC) has been trending somewhat positive on Tuesday, Accern Sentiment reports. Accern scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Quorum Health Corporation earned a daily sentiment score of 0.11 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.4297383385908 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:

Quorum Health Corporation (QHC) traded up 0.53% during midday trading on Tuesday, hitting $5.72. The stock had a trading volume of 76,929 shares. The stock has a 50-day moving average of $4.96 and a 200-day moving average of $4.96. Quorum Health Corporation has a 52 week low of $2.54 and a 52 week high of $9.46. The firm’s market cap is $173.30 million.

Quorum Health Corporation (NYSE:QHC) last posted its quarterly earnings data on Wednesday, August 9th. The company reported ($0.42) earnings per share for the quarter, topping the consensus estimate of ($0.66) by $0.24. The company had revenue of $530.15 million during the quarter, compared to analysts’ expectations of $513.50 million. Quorum Health Corporation had a negative return on equity of 26.69% and a negative net margin of 6.88%. Quorum Health Corporation’s revenue for the quarter was up .1% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.82) earnings per share. Analysts forecast that Quorum Health Corporation will post ($1.55) EPS for the current fiscal year.

QHC has been the subject of several research analyst reports. Zacks Investment Research raised Quorum Health Corporation from a “hold” rating to a “buy” rating and set a $4.50 price objective for the company in a research note on Saturday, July 22nd. Royal Bank Of Canada reissued a “hold” rating and issued a $5.00 price objective on shares of Quorum Health Corporation in a research note on Tuesday, October 3rd. Deutsche Bank AG increased their price objective on Quorum Health Corporation from $3.00 to $3.50 and gave the stock a “hold” rating in a research note on Monday, August 14th. Credit Suisse Group increased their price objective on Quorum Health Corporation from $3.00 to $4.00 and gave the stock a “neutral” rating in a research note on Monday, August 14th. Finally, ValuEngine raised Quorum Health Corporation from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st. Three investment analysts have rated the stock with a sell rating and four have given a hold rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $4.13.

WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at

About Quorum Health Corporation

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).

Insider Buying and Selling by Quarter for Quorum Health Corporation (NYSE:QHC)

Receive News & Stock Ratings for Quorum Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health Corporation and related stocks with our FREE daily email newsletter.